VREOF
Vireo Growth Inc.
Overview
Vireo Growth Inc. operates a vertically integrated cannabis company that cultivates, manufactures, and retails cannabis products across six U.S. states—Maryland, Minnesota, Missouri, Nevada, New York, and Utah.
Vireo Growth Inc is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $773.5M market cap.
Most recent earnings call: Q1 FY26 on May 12, 2026.
14 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-127 Q&A exchanges
- Q2 FY2025Earnings2025-08-139 Q&A exchanges
- Q1 FY2025Earnings2025-05-096 Q&A exchanges
- Q4 FY2024Earnings2025-03-048 Q&A exchanges
- Q3 FY2024Earnings2024-11-136 Q&A exchanges
- Q1 FY2024Earnings2024-05-078 Q&A exchanges
- Q4 FY2023Earnings2024-04-0114 Q&A exchanges
- Q3 FY2023Earnings2023-11-146 Q&A exchanges
- Q2 FY2023Earnings2023-08-149 Q&A exchanges
- Q1 FY2023Earnings2023-05-156 Q&A exchanges
- Q4 FY2022Earnings2023-04-031 Q&A exchange
- Q3 FY2022Earnings2022-11-154 Q&A exchanges
- Q3 FY2021Earnings2021-11-1012 Q&A exchanges
- Q1 FY2021Earnings2021-05-1411 Q&A exchanges
History
Earnings history
Reported quarters with consensus, surprise, and 1-day reaction context.
Track Record
SampleSpoken Alpha tracks VREOF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 60% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 6 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.45 | $4.05 | +9.8% | +6.3% | +7.3% |
| Q4 FY2026 | $4.33 | $4.10 | +5.6% | -3.9% | -1.6% |
| Q3 FY2026 | $4.51 | $4.14 | +9.0% | -1.6% | -1.6% |
| Q2 FY2026 | $4.91 | $4.25 | +15.5% | +2.1% | +2.0% |
| Q1 FY2025 | $4.76 | $4.19 | +13.5% | +4.5% | +1.6% |
| Q4 FY2025 | $4.96 | $4.21 | +17.9% | +2.0% | -0.7% |
| Q3 FY2025 | $4.44 | $4.34 | +2.2% | +4.6% | +6.5% |
| Q2 FY2025 | $4.68 | $4.34 | +7.9% | +3.7% | +6.4% |
| Q1 FY2024 | $4.94 | $4.20 | +17.6% | -3.8% | -6.7% |
| Q4 FY2024 | $4.90 | $4.26 | +15.0% | -1.8% | -3.2% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Maintained2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- John MazarakisCEO1 yr 1 mo3 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last call held guidance Q1 FY2026
- Tyson MacDonaldCFO1 yr 6 mo3 callsCurrentSample
CFO since 2024 • 4/8 beats (50%) • last call held guidance Q2 FY2026
- Amber Holly ShimpaPresident1 yrno recorded callsCurrentSample
PRESIDENT since 2025 • 2/4 beats (50%) • guidance suspended Q3 FY2026
- Joseph DuxburyChief Accounting Officer1 yr 6 mo1 callCurrentSample
OTHER_C_SUITE since 2024 • 3/8 beats (38%) • last call held guidance Q2 FY2026
- Sean Michael ApfelbaumGC and Corporate Secretary10 mono recorded callsCurrentSample
OTHER since 2025 • 2/4 beats (50%) • guidance suspended Q1 FY2026
- Kyle Eugene KingsleyCo-Executive Chairman1 yr 6 mono recorded callsCurrentSample
OTHER since 2024 • 3/8 beats (38%) • last call held guidance Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for VREOF.
$ curl https://api.spokenalpha.com/v1/companies/VREOFFAQ
Frequently asked about VREOF
Where can I find Vireo Growth Inc.'s (VREOF) earnings call transcripts?
Spoken Alpha indexes VREOF's earnings call transcripts at https://spokenalpha.com/companies/VREOF. Each call links to attributed speakers and parsed analyst Q&A. Vireo Growth Inc.'s own investor relations page is at https://investors.vireogrowth.com/home/default.aspx.
When was Vireo Growth Inc.'s most recent earnings call?
Vireo Growth Inc. (VREOF) held its most recent earnings call on 2026-05-12, covering fiscal Q1 2026.
What sector is VREOF in?
Vireo Growth Inc. (VREOF) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).